Log In
Print this Print this

H5N1 influenza vaccine (HAI-05)

  Manage Alerts
Collapse Summary General Information
Company iBio Inc.
DescriptionRecombinant hemagglutinin (rHA) vaccine derived from avian (H5N1) influenza virus
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsVaccinate against avian (H5N1) influenza virus
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today